PRMT5 and neoplasm: Alternatively, protein arginine methyltransferase 5 (PRMT5) was described as a prostate cancer oncogene driving cancer cell growth through epigenetic inactivation of several tumor suppressors [11] through histone arginine methylation at H4R3.